500 Shares in Encompass Health Co. (NYSE:EHC) Acquired by Tompkins Financial Corp

Tompkins Financial Corp acquired a new stake in Encompass Health Co. (NYSE:EHC) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 500 shares of the company’s stock, valued at approximately $46,000.

A number of other institutional investors have also recently bought and sold shares of the business. UMB Bank n.a. boosted its stake in Encompass Health by 387.7% during the 3rd quarter. UMB Bank n.a. now owns 317 shares of the company’s stock worth $31,000 after acquiring an additional 252 shares during the last quarter. V Square Quantitative Management LLC boosted its position in shares of Encompass Health by 53.0% during the third quarter. V Square Quantitative Management LLC now owns 404 shares of the company’s stock worth $39,000 after purchasing an additional 140 shares in the last quarter. Avior Wealth Management LLC acquired a new position in shares of Encompass Health in the 3rd quarter valued at $40,000. Benjamin F. Edwards & Company Inc. increased its position in shares of Encompass Health by 58.9% in the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 534 shares of the company’s stock valued at $46,000 after buying an additional 198 shares in the last quarter. Finally, Point72 Asia Singapore Pte. Ltd. acquired a new stake in Encompass Health during the 2nd quarter worth $58,000. Institutional investors and hedge funds own 97.25% of the company’s stock.

Wall Street Analyst Weigh In

EHC has been the subject of several recent analyst reports. KeyCorp increased their price target on Encompass Health from $115.00 to $117.00 and gave the stock an “overweight” rating in a report on Tuesday, October 29th. Royal Bank of Canada increased their target price on Encompass Health from $105.00 to $110.00 and gave the stock an “outperform” rating in a research note on Wednesday, October 30th. Barclays lifted their price target on shares of Encompass Health from $109.00 to $116.00 and gave the company an “overweight” rating in a research note on Tuesday, October 29th. UBS Group boosted their price objective on shares of Encompass Health from $100.00 to $110.00 and gave the company a “buy” rating in a research report on Wednesday, September 25th. Finally, Truist Financial reiterated a “buy” rating and set a $116.00 target price (up previously from $108.00) on shares of Encompass Health in a report on Wednesday, October 30th. Nine equities research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Buy” and an average target price of $107.11.

Encompass Health Trading Up 0.3 %

Encompass Health stock opened at $94.68 on Friday. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.04 and a quick ratio of 1.04. The firm has a 50-day moving average of $97.39 and a 200-day moving average of $93.94. The company has a market cap of $9.54 billion, a price-to-earnings ratio of 22.87, a P/E/G ratio of 1.09 and a beta of 0.89. Encompass Health Co. has a one year low of $69.76 and a one year high of $104.55.

Encompass Health (NYSE:EHC) last posted its quarterly earnings results on Monday, October 28th. The company reported $1.03 earnings per share for the quarter, beating analysts’ consensus estimates of $0.94 by $0.09. The firm had revenue of $1.35 billion during the quarter, compared to the consensus estimate of $1.33 billion. Encompass Health had a return on equity of 17.60% and a net margin of 8.10%. The business’s revenue was up 11.9% compared to the same quarter last year. During the same period last year, the company earned $0.86 earnings per share. On average, equities analysts expect that Encompass Health Co. will post 4.29 earnings per share for the current fiscal year.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.